Does Actemra access solutions offer co-pay assistance?
For eligible patients with commercial or public health insurance, ACTEMRA Access Solutions offers referrals to independent co-pay assistance foundations.*
How do I contact Genentech for more information about Actemra® supply?
For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here. Genentech Patient Foundation
What is Actemra used to treat?
Important Safety Information & Indication. ACTEMRA is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs).
How do I Opt Out of RSVP with Actemra?
ACTEMRA patients enrolled in ACTEMRA Access Solutions are automatically enrolled in RSVP. Use this form to opt out of this program. Use this cover sheet when faxing documents to ACTEMRA Access Solutions.
What is the cost of Actemra?
Actemra (tocilizumab) is a member of the interleukin inhibitors drug class and is commonly used for COVID-19, Cytokine Release Syndrome, Giant Cell Arteritis, and others....Intravenous Solution.QuantityPer unitPrice10 milliliters$130.24$1,302.4220 milliliters$129.77$2,595.331 more row
How often are Actemra infusions?
The usual IV infusion dosing of Actemra for RA is 4 mg per kg, given once every 4 weeks. For example, a person weighing 75 kg (about 165 lb) would receive 300 mg of Actemra once every 4 weeks. If needed, your doctor may increase your dosage to 8 mg per kg once every 4 weeks.
Should I take Actemra?
You should not take any prescription drug, including Actemra, unless your doctor recommends it. For information about prevention and treatment, as well as expert advice, at our COVID-19 hub.
What is Genentech Patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance coverage or who have financial concerns and meet eligibility criteria.
Is ACTEMRA a high risk medication?
Actemra has a boxed warning for risk of serious infections, including tuberculosis (TB). A boxed warning is the most serious warning from the FDA. Some infections from Actemra may be serious enough to cause you to stay in the hospital. In rare cases, infections from Actemra can be fatal.
How do you feel after ACTEMRA infusion?
The most common Actemra (tocilizumab) side effects include runny or stuffy nose, sore throat, sinus infection, headache, high blood pressure and injection site reactions.
How long should you take ACTEMRA?
The recommended dose of ACTEMRA intravenous (IV) infusions for GCAEvery 4 weeks, you will receive a 60-minute-long IV infusion in combination with a tapering steroid treatment.The dose of ACTEMRA IV you receive will be based on your weight.ACTEMRA IV can be used alone after steroids have been stopped.
What can I use instead of ACTEMRA?
Are Orencia and Actemra the Same Thing? Orencia (abatacept) and Actemra (tocilizumab) are used to treat the symptoms of rheumatoid arthritis. Orencia is also used to treat arthritis in children who are at least 6 years old.
Can ACTEMRA cause memory loss?
In addition to the more serious Actemra symptoms, some of those taking the drug have claimed to have memory lapses, brain fog, mental sluggishness, small strokes, an increase in cholesterol levels, hair loss, tremors and the heart-rhythm disorder tachycardia after taking Actemra.
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
Who makes Valganciclovir?
Genentech: Valcyte® (valganciclovir hydrochloride) - Information for Patients.
How long does ACTEMRA infusion last?
ACTEMRA IV Administration ACTEMRA is administered as a 60-minute single intravenous drip infusion. Doses exceeding 800 mg per infusion are not recommended.
How long does ACTEMRA infusion take to work?
ACTEMRA IV infusions, taken without methotrexate, started to work in as little as 2 weeks in some patients. Individual results may vary.
How long does ACTEMRA last?
It may also depend on your body weight and whether you receive Actemra as an injection under your skin or as an intravenous (IV) infusion. (An IV infusion is an injection into your vein given over time.) Based on the half-life of Actemra, the drug may stay in your system for up to 13 weeks.
What is the best IV infusion for rheumatoid arthritis?
Disease-modifying antirheumatic drugs (DMARDs) are widely regarded as the most effective infusion therapy for rheumatoid arthritis. To reduce inflammation, DMARDs target special proteins in your body or inflammatory chemicals that your body produces on a cellular level.
What is ACTEMRA Access Solutions?
For eligible patients with commercial or public health insurance, ACTEMRA Access Solutions offers referrals to independent co-pay assistance foundations.†
Who provides Genentech medicine?
The Genentech Patient Foundation provides free Genentech medicine to people who don't have insurance coverage or who have financial concerns and to people who meet certain income criteria.*
Does ACTEMRA have a copay card?
ACTEMRA Access Solutions can refer eligible patients to the ACTEMRA Co-pay Card Program for help with the out-of-pocket costs associated with their Genentech medicine.*
What should I tell my healthcare provider before receiving ACTEMRA?
ACTEMRA may not be right for you. Before receiving ACTEMRA, tell your healthcare provider if you:
What are the side effects of ACTEMRA?
These blood tests are to check for the following side effects of ACTEMRA: Low neutrophil count: neutrophils are white blood cells that help the body fight infection. Low platelet count: platelets are blood cells that help with clotting, which stops bleeding. Increase in liver function test levels.
How long after ACTEMRA can you check cholesterol?
Increase in blood cholesterol levels: your cholesterol levels should be checked 4 to 8 weeks after you start receiving ACTEMRA.
How to report side effects of Genentech?
You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555. Please see full Prescribing Information and the Medication Guide, including Serious Side Effects, for more Important Safety Information.
Can you take actherma with diverticulitis?
If you have diverticulitis (inflammation in parts of the large intestine), talk to your healthcare provider before taking ACTEMRA. Some people taking ACTEMRA may develop a hole in the wall of their stomach or intestines (also known as a perforation). This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or methotrexate.
Should you test for TB before taking ACTEMRA?
Your healthcare provider should test you for TB before starting and during treatment with ACTEMRA. Before starting ACTEMRA, tell your healthcare provider if you have: an infection, think you may have an infection, are being treated for an infection, or get a lot of infections that return.
Can you die from actherma?
Serious allergic reactions, including death, can happen with ACTEMRA. These reactions can happen with any infusion or injection of ACTEMRA, even if they did not occur with an earlier infusion or injection. Tell your healthcare provider before your next dose if you had hives, rash or flushing after your injection.
What is ACTEMRA used for?
ACTEMRA is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs). ACTEMRA is indicated for the treatment of giant cell arteritis (GCA) in adult patients.
Where to report side effects of Actemra?
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
How many ISRs are there in ACTEMRA SC?
During the 1-year study, a frequency of 28.8% (15/52) ISRs was observed in ACTEMRA-SC treated PJIA patients. These ISRs occurred in a greater proportion of patients at or above 30 kg (44.0%) compared with patients below 30 kg (14.8%). All ISRs were mild in severity and none of the ISRs required patient withdrawal from treatment or dose interruption.
What are the most common adverse reactions to methotrexate?
The most common serious adverse reactions were serious infections. The most common serious infections included pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis and bacterial arthritis. In the ACTEMRA-IV monotherapy clinical study, the rate of serious infections was 3.6 per 100 patient-years in the ACTEMRA group and 1.5 per 100 patient-years in the methotrexate group. The rate of serious infections in the 4 mg/kg and 8 mg/kg ACTEMRA plus DMARD groups was 4.4 and 5.3 events per 100 patient-years, respectively, compared to 3.9 events per 100 patient-years in the placebo plus DMARD group.
How long does it take for ACTEMRA to show signs of liver damage?
Some of these cases have resulted in liver transplant or death. Time to onset for cases ranged from months to years after treatment initiation. Most cases presented with marked elevations of transaminases (> 5 times ULN), and some cases presented with signs or symptoms of liver dysfunction and only mildly elevated transaminases.
What are the most common adverse events in ACTEMRA IV?
The most common adverse events (at least 5%) seen in ACTEMRA-IV treated patients in the 12-week controlled portion of the study were: upper respiratory tract infections, headache, nasopharyngitis, and diarrhea.
What is the rate of infection in actrea IV?
The rate of infections in the ACTEMRA-IV all-exposure population was 163.7 per 100 patient-years. The most common events observed were nasopharyngitis and upper respiratory tract infections. The rate of serious infections was numerically higher in patients weighing less than 30 kg treated with 10 mg/kg ACTEMRA-IV (12.2 per 100 patient-years) compared to patients weighing at or above 30 kg, treated with 8 mg/kg ACTEMRA-IV (4.0 per 100 patient-years). The incidence of infections leading to dose interruptions was also numerically higher in patients weighing less than 30 kg treated with 10 mg/kg ACTEMRA-IV (21%) compared to patients weighing at or above 30 kg, treated with 8 mg/kg ACTEMRA-IV (8%).
What are the most common adverse events seen in ACTEMRA IV?
The most common adverse events seen in ACTEMRA-IV all-exposure population included: upper respiratory tract infections, headache, nasopharyngitis, and diarrhea.
How many infections are there in ACTEMRA IV?
In the 12-week controlled phase, the rate of all infections in the ACTEMRA-IV group was 345 per 100 patient-years and 287 per 100 patient-years in the placebo group. In the open-label extension over an average duration of 73 weeks of treatment, the overall rate of infections was 304 per 100 patient-years.
How many ISRs are there in ACTEMRA SC?
During the 1-year study, a frequency of 28.8% (15/52) ISRs was observed in ACTEMRA-SC treated PJIA patients. These ISRs occurred in a greater proportion of patients at or above 30 kg (44.0%) compared with patients below 30 kg (14.8%). All ISRs were mild in severity and none of the ISRs required patient withdrawal from treatment or dose interruption.
What are the most common adverse reactions to methotrexate?
The most common serious adverse reactions were serious infections. The most common serious infections included pneumonia, urinary tract infection, cellulitis, herpes zoster, gastroenteritis, diverticulitis, sepsis and bacterial arthritis. In the ACTEMRA-IV monotherapy clinical study, the rate of serious infections was 3.6 per 100 patient-years in the ACTEMRA group and 1.5 per 100 patient-years in the methotrexate group. The rate of serious infections in the 4 mg/kg and 8 mg/kg ACTEMRA plus DMARD groups was 4.4 and 5.3 events per 100 patient-years, respectively, compared to 3.9 events per 100 patient-years in the placebo plus DMARD group.
How long does it take for ACTEMRA to show signs of liver damage?
Some of these cases have resulted in liver transplant or death. Time to onset for cases ranged from months to years after treatment initiation. Most cases presented with marked elevations of transaminases (> 5 times ULN), and some cases presented with signs or symptoms of liver dysfunction and only mildly elevated transaminases.
Is ACTEMRA recommended for elevated liver enzymes?
Elevated Liver Enzymes: It is not recommended to initiate ACTEMRA treatment in patients with elevated transaminases ALT or AST >1.5x ULN. In patients who develop elevated ALT or AST >5x ULN, treatment is not recommended.
Is actema contraindicated?
ACTEMRA is contraindicated in patients with known hypersensitivity to ACTEMRA.
What is Genentech Patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance or who have financial concerns and meet eligibility criteria. Two forms are needed to enroll in the Genentech Patient Foundation:
Is Actemra a RSVP?
ACTEMRA ® (tocilizumab) patients enrolled in ACTEMRA Access Solutions are automatically enrolled in RSVP. Use this form to opt out of this program.
What is ACTEMRA access?
If you need help with the co-pay for your Genentech medicine, ACTEMRA Access Solutions can refer you to an independent co-pay assistance foundation. An independent co-pay assistance foundation is a charitable organization that gives financial assistance for medicines. Call ACTEMRA Access Solutions at (866) 681-3261 for a referral.
How to contact ACTEMRA?
Call ACTEMRA Access Solutions at (866) 681-3261 for a referral. These foundations may be able to help you. Please check their websites for up-to-date information.
What is ACTEMRA Access Solutions number?
At this time, no independent co-pay assistance foundations have been identified. Please call ACTEMRA Access Solutions at (866) 681-3261 for assistance.
What is ACTEMRA copay card?
The ACTEMRA Co-pay Card Program helps patients with commercial health insurance. This might be a plan you get through your employer or one you purchased through a Health Insurance Marketplace like HealthCare.gov. To qualify, you must also meet other criteria.
Who gives Genentech medicine?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance coverage or who have financial concerns and meet certain eligibility criteria.
Does ACTEMRA have copay assistance?
If you have public insurance or commercial insurance, ACTEMRA Access Solutions can refer you to an independent co-pay assistance foundation that might help pay for your Genentech medicine.
How to contact Genentech about Actemra?
Medicine Information Support. Ask about possible side effects and any other medical questions related to your prescribed Genentech medicine. Call us at (800) 821-8590, Monday-Friday, 5am-5pm PT. Chat with us using our live chat feature, Monday-Friday, 5am-5pm PT.
How old do you have to be to get PJIA?
To treat people with active polyarticular juvenile idiopathic arthritis (PJIA) 2 years of age and older
How to report side effects of Genentech?
You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555. Please see full Prescribing Information and the Medication Guide, including Serious Side Effects, for more Important Safety Information.
Can ACTEMRA cause multiple sclerosis?
While rare, Multiple Sclerosis has been diagnosed in people who take ACTEMRA.
Does actuma increase cancer risk?
ACTEMRA may increase your risk of certain cancers by changing the way your immune system works .
Can you get actherma if your neutrophils are low?
Changes in Blood Test Results. Your healthcare provider should do blood tests before and after you start receiving ACTEMRA. You should not receive ACTEMRA if your neutrophil and platelet counts are too low or your liver function test levels are too high.
Can you take actherma with diverticulitis?
If you have diverticulitis (inflammation in parts of the large intestine), talk to your healthcare provider before taking ACTEMRA. Some people taking ACTEMRA may develop a hole in the wall of their stomach or intestines (also known as a perforation).
How to contact Genentech about compassionate use?from gene.com
If you are seeking information about access to one of Genentech's investigational medicines, please call Genentech's Clinical Trial Information Support Line at (888) 662-6728 or Genentech's Compassionate Use Information Line at (844) ...
What is GSF patient library?from geneticsupportfoundation.org
GSF has a Patient Library that provides more background information on a variety of topics in genetics, including a genetics overview (Genetics 101), Genetics & Pregnancy, and Genetics & Cancer, among others. Learn more.
Do you need to complete a patient consent form?from gene.com
Both forms are required. No action can be taken until a completed Patient Consent Form and Prescriber Service Form have been received.
